Soon, Provenge will be available for terminally ill prostate cancer patients. This therapy should have been available to such patients two years ago. Published on: www.psa-rising.com The Unreachable Unavailability of Provenge *FDA’s mission statement: To...
The Conversion of Our Protector The Food and Drug Administration originated in its primitive form several decades ago to ensure the health and safety of the citizens of the United States in regards to...